Anti-Obesity Prescription Drugs Market to See Huge Growth by 2025 : Vivus, Orexigen Therapeutics, Novo Nordisk
Global Anti-Obesity Prescription Drugs Market Insights, Forecast to 2025 is latest research study released by HTF MI evaluating the market, highlighting opportunities, risk side analysis, and leveraged with strategic and tactical decision-making support. The study provides information on market trends and development, drivers, capacities, technologies, and on the changing investment structure of the Global Anti-Obesity Prescription Drugs Market. Some of the key players profiled in the study are F Hoffmann La Roche Ltd, Orexigen Therapeutics, Novo Nordisk A/s, Arena Pharmaceuticals,...
View full press release